Ypsomed Holding AG - Company Profile
Powered by
All the data and insights you need on Ypsomed Holding AG in one report.
- Save hours of research time and resources with
our up-to-date Ypsomed Holding AG Strategy Report
- Understand Ypsomed Holding AG position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Ypsomed Holding AG (Ypsomed) is a medical device company that designs, develops and manufactures insulin systems, and injection systems and pen needles for the treatment of diabetes, growth disorders, infertility, and various other conditions. The improved performance of the Ypsomed delivery systems, presence in major geographical markets, and focus on research and development activities are the strengths of the company, even as decline performance in Ypsomed diabetes care segment could be a cause for concern. The company could benefit from the growing diabetes care device market, global drug delivery device market and strategic partnerships. However, its performance could be affected by rapid technological changes, stringent regulatory environment and stiff competition.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer